Market Overview - The overall market experienced a decline, with the Shanghai Composite Index, Shenzhen Component Index, and ChiNext Index falling by 0.75%, 1.1%, and 1.13% respectively, as over 4,400 stocks declined and only around 800 stocks rose [4] - The drop was primarily seen in previously strong stocks and themes, indicating a potential negative impact on market sentiment [5] Oil and Gas Sector - The oil and gas sector opened strong due to geopolitical tensions between Israel and Iran, leading to a significant rise in oil futures [6] - Notable stocks such as Junyou Co., Beiken Energy, and others hit the daily limit up, with the oil and gas and oil service sectors closing up by 1.18% and 5.26% respectively [8][7] Gold Sector - The gold sector also saw a strong performance, with stocks like Xiaocheng Technology and others rising significantly, leading to an overall increase of 4.17% in the gold sector [8] Military Industry - The military sector, particularly focused on nuclear pollution prevention and large aircraft concepts, saw stocks like Jieqiang Equipment and others hit the daily limit up, with the sector closing up by 3.6% [12][14] Digital Currency and Stablecoin - News regarding Ant Group's plans to apply for stablecoin licenses in Hong Kong and Singapore led to a surge in related stocks, with companies like Hefei Urban Construction and Junzheng Group experiencing significant gains [18][20] - The market reacted positively to the stablecoin concept, with various stocks showing strong performance, although some experienced high volatility [22][23]

Group 1 - The nuclear pollution prevention concept sector saw a rise of 4.35%, ranking second among concept sectors, with 36 stocks increasing in value [1][2] - Notable stocks that hit the 20% limit up include Hengguang Co., Jiekang Equipment, and Zhongjin Irradiation, while stocks like Hanwei Technology and Yingliu Co. experienced declines [1][2] - The sector attracted a net inflow of 1.26 billion yuan from main funds, with 33 stocks receiving net inflows, and 14 stocks exceeding 50 million yuan in net inflows [2][3] Group 2 - The top three stocks by net inflow ratio were Jiekang Equipment (31.53%), Jihua Group (26.72%), and Zhongguang Nuclear Technology (24.36%) [3] - The leading stocks in the nuclear pollution prevention concept based on net inflow included Jihua Group, Beihua Co., and Zhongguang Nuclear Technology, with net inflows of 174 million yuan, 151 million yuan, and 140 million yuan respectively [2][3] - The overall trading performance of the sector was strong, with several stocks showing significant increases in turnover rates and net inflow ratios [3][4]

Market Overview - The Shanghai Composite Index experienced fluctuations, while the Shenzhen Component and ChiNext Index both fell over 1%. Oil and gas stocks surged, with companies like Xinjin Power and Tongyuan Petroleum hitting the daily limit. Nuclear pollution prevention concepts also saw gains, with stocks like Jieqiang Equipment and CGN Technology reaching their limits. Gold stocks collectively strengthened, with Western Gold and Cuihua Jewelry hitting the daily limit. The beauty care sector declined, with Shuiyang shares dropping over 10%. Overall, more than 4,500 stocks in the Shanghai and Shenzhen markets were in the red, with a total transaction volume of 1.5 trillion yuan [1]. Hot Topics Oil Services - The oil service sector saw significant gains, with stocks like Zhun Oil and Beiken Energy hitting the daily limit. Following an Israeli attack on Iran, WTI crude oil futures rose by over 10% [4][5]. - Zhun Oil shares rose by 9.94% to 6.86 yuan, with a market cap of 1.789 billion yuan. Beiken Energy increased by 10.03% to 10.09 yuan, with a market cap of 1.957 billion yuan. Libet shares rose by 10% to 12.54 yuan, with a market cap of 5.631 billion yuan [5]. Nuclear Pollution Prevention - Stocks related to nuclear pollution prevention also surged, with Jieqiang Equipment, Beihua Co., and Huashengchang hitting their daily limits. Reports indicated that Israel attacked nuclear facilities in Iran, which contributed to the rise in these stocks [7][8]. - Jieqiang Equipment shares increased by 20.01% to 31.43 yuan, with a market cap of 2.692 billion yuan. Beihua Co. rose by 10.01% to 14.29 yuan, with a market cap of 7.846 billion yuan [8]. Military Industry - The military sector also experienced an uptick, with companies like Hainengda and Chengfei Integration hitting their daily limits. The upcoming Paris Air Show, scheduled for June 16-22, is expected to further boost this sector [9][10]. - Hainengda shares rose by 10.03% to 12.51 yuan, with a market cap of 16.047 billion yuan. Chengfei Integration increased by 10.01% to 36.72 yuan, with a market cap of 13.173 billion yuan [10]. Other Observations - Gold stocks, shipping, and blockchain sectors showed localized rotations, while the IP economy, media, and consumer sectors faced the largest declines [11].

以色列跟伊朗开打之后，全球市场动荡。 全球大跌 6月13日，以色列对伊朗核项目发动了大规模袭击，一名以色列军方官员称，此次袭击针对的是伊朗的核项目和其他军事设施，以及伊朗的 军事指挥官和核科学家。以色列方面表示，周五拂晓前，数十架飞机完成了第一波攻击。 以色列总理本雅明·内塔尼亚胡表示："我们打击了伊朗核浓缩项目的核心。我们打击了伊朗核武器化项目的核心。我们袭击了伊朗位于纳 坦兹的主要浓缩设施。我们袭击了参与伊朗核弹研究的主要核科学家。我们还打击了伊朗弹道导弹项目的核心。" 在美国和以色列官员警告袭击迫在眉睫数小时后，此次袭击就发生了，并打断了美国牵头的通过外交途径解决伊朗核项目僵局的努力。 特朗普本周早些时候批准撤离部分在中东的美方人员，指出该地区"可能变得危险"。 他在周四对媒体表示，以色列的打击"看起来很可能会发生"，但他强调美国更希望通过谈判达成核浓缩协议，而不是看到军事冲突。 他说："我更倾向于与伊朗达成协议，只要我认为有可能达成协议。我并不希望以色列出兵，因为我觉得那可能会破坏协议。尽管也可能促 进达成协议，但也可能彻底毁掉它。我们和伊朗进行了非常好的讨论。" 伊朗已警告称，将对任何袭击予以反击， ...

Market Overview - The three major A-share indices collectively declined in the morning session, with the Shanghai Composite Index down 0.72%, the Shenzhen Component Index down 1.15%, and the ChiNext Index down 1.14% [1] - The total market turnover reached 936.1 billion yuan, an increase of 140 billion yuan compared to the previous day, with over 4,400 stocks declining [1] Sector Performance - The oil and gas, precious metals, and nuclear pollution prevention sectors showed strong gains, while the medical beauty, e-commerce, gaming media, and pharmaceutical sectors experienced significant declines [2] - Notable performers included Keli Co., Ltd. with a 30% limit up, and several other stocks in the oil and gas sector also hitting the limit up [2] - Precious metals stocks, such as Western Gold, also reached the limit up, while medical beauty concept stocks like Huaye Fragrance and Shuiyang Co. fell over 10% [2] Hot Topics - The "Belt and Road" initiative saw 12 stocks hitting the limit up, with two stocks achieving consecutive limit ups, including Hars Co. and Yong'an Pharmaceutical [8] - The Russia-Ukraine conflict concept had 9 stocks hitting the limit up, with representatives including Beiken Energy and Deshi Co. [8] - The natural gas sector also had 9 stocks hitting the limit up, with Beiken Energy and Deshi Co. as notable mentions [9] Specific Stock Movements - Keli Co., Ltd. led with a five-day limit up streak, while Hars Co. and Yingli Automotive achieved three consecutive limit ups [5][6] - Several stocks, including Xiamen Xinda and Annie Co., achieved two consecutive limit ups [7] News Impact - Oil prices surged following airstrikes on Iranian military facilities, with WTI crude oil futures rising 10% to $74.99 per barrel, the highest since February 3 [10] - Gold futures also saw a rise of 2.46%, surpassing the 800 yuan mark for the first time since May 8, amid escalating tensions in the Middle East due to Israeli airstrikes on Iran [11]

Group 1 - The nuclear pollution prevention sector has seen significant gains, with companies like China General Nuclear Power Technology (000881) reaching the daily limit increase [1] - Other companies in the sector, such as Jieqiang Equipment (300875), Beihua Co., Ltd. (002246), and Huashengchang (002980), also experienced a surge, hitting their daily limit [1] - Zhongjin Irradiation (300962) rose nearly 19%, indicating strong market interest in nuclear-related stocks [1] Group 2 - Additional companies like China Electric Environmental Protection (300172), Rongji Software (002474), and others also followed the upward trend, reflecting a broader market movement in this sector [1] - The overall positive sentiment in the nuclear pollution prevention sector suggests potential investment opportunities as more companies join the rally [1]

Core Insights - The report indicates that the global metal industry is still in a weak supply cycle, with exploration investments declining for the second consecutive year, down 3% to $12.5 billion in 2024 [3] - The magnesium industry is expected to enter a state of sustained tight balance, while the lithium industry is gradually improving its oversupply situation [2][11] Supply and Demand Analysis - Global mining supply growth is significantly constrained, with actual supply growth dropping from 6.35% to 2.22% in 2024, which is only 49.8% of the average growth rate over the past 30 years [4] - China's actual supply growth for ten non-ferrous metals is projected to remain within the fluctuation range observed since 2012, averaging 6.79% from 2023 to 2024 [4] Industry Trends - The report emphasizes the cyclical, growth, and hedging value of the metal industry, highlighting three main lines of focus: industrial metals with resilient supply-demand states, small metals with enhanced growth attributes, and precious metals with tight supply-demand fundamentals [7] - The proportion of holdings in the non-ferrous metal sector has significantly increased, reaching a historical high of 5.43% in Q1 2024, although it is expected to decline to 2.85% by Q4 2024 due to economic weakness and declining downstream demand [8] Magnesium Industry Insights - The magnesium industry is forming a new modern industrial cluster in China, which is expected to enhance scale efficiency and profitability, aligning with the development of the new energy industry [9] - Global magnesium production is projected to increase from 1.12 million tons in 2024 to 2 million tons by 2027, with a compound annual growth rate (CAGR) of 21% [9] Lithium Industry Insights - The lithium industry is expected to see a gradual improvement in supply-demand dynamics, with global lithium supply projected to grow from 1.231 million tons LCE in 2024 to 1.86 million tons LCE by 2027, reflecting a CAGR of 15% [11] - The demand for lithium is driven by the growth of the electric vehicle market and energy storage systems, with total lithium battery shipments expected to rise from 1,545 GWh in 2024 to 2,778 GWh by 2027 [11] Investment Opportunities - The report identifies key companies in the magnesium sector, such as Baowu Magnesium and Xingyuan Zhuomai, and in the lithium sector, including Tianqi Lithium, Ganfeng Lithium, Yongxing Materials, and Jinyinhai [10][12]

Core Viewpoint - The proton medical business of China General Nuclear Power Technology Development Co., Ltd. (CGN Tech) has received support from its controlling shareholder, which is expected to facilitate the development of this business segment [2][4]. Group 1: Investment and Financial Support - The controlling shareholder, China General Nuclear Technology Application Co., Ltd., plans to inject 500 million yuan into CGN Tech's wholly-owned subsidiary, CGN Medical Technology (Mianyang) Co., Ltd., to support the research and development of proton medical projects [2]. - After the capital increase, the controlling shareholder will hold 44.13% of the shares in Mianyang Medical, while CGN Tech's shareholding will decrease to 55.87%, transforming Mianyang Medical from a wholly-owned subsidiary to a controlled subsidiary [4]. Group 2: Business Development and Market Potential - CGN Tech's medical health business began in 2020, focusing on the introduction of multi-room proton therapy technology from Belgium's IBA and establishing a manufacturing base for proton medical equipment in Mianyang, Sichuan [2]. - Proton therapy is recognized for its high precision, low side effects, and shorter treatment duration, making it increasingly popular among doctors and patients [3]. - The company has made significant progress in its proton medical business, including the development of a compact proton therapy system with independent intellectual property rights and the completion of its proton industry park, which has commenced production [3][4]. Group 3: Industry Insights - The demand for proton medical equipment is expected to grow due to increasing health awareness and advancements in medical technology, indicating a broad development space for this sector [3]. - The cash injection from the controlling shareholder is anticipated to alleviate financial pressure on CGN Tech and enhance its core competitiveness in the medical health business [5].

Policy Developments - The Central Committee and State Council issued an opinion to improve the adjustment mechanism for the basic medical insurance drug catalog and to establish an innovative drug catalog for commercial health insurance [2] - The opinion aims to promote the sharing of high-quality medical resources and enhance the capacity of grassroots medical institutions [2] - The commercial health insurance sector is becoming a crucial lever for the high-quality development of commercial health insurance, helping to address the payment challenges for innovative drugs [3] Medical Device Approvals - DaAn Gene obtained a medical device registration certificate for six nucleic acid test kits for respiratory pathogens, expanding its product portfolio [5] - BGI Innovation received a medical device registration certificate for a human papillomavirus genotyping test kit, classified as Class III [6] - Shanghai Pharmaceuticals received approval for the production of Formoterol Fumarate inhalation solution, which is used for the maintenance treatment of chronic obstructive pulmonary disease [7] Corporate Transactions - Pilin Bio announced the resumption of trading after China National Pharmaceutical Group acquired 21.03% of its shares, changing the controlling shareholder [8] - China General Nuclear Power Corporation plans to inject 500 million yuan into its subsidiary for proton medical research and development [9] - Zhonghui Pharmaceutical completed two rounds of financing totaling nearly 50 million yuan, which will be used for the construction of a hollow microneedle medical device production base [10] Industry Developments - Dongxing Medical's subsidiary signed two contracts with Shanghai Jiao Tong University for synthetic biology technology development, totaling 6 million yuan [11] Regulatory Alerts - Huahai Pharmaceutical received a warning letter from the FDA regarding its production facility, which may affect future ANDA applications but will not significantly impact current performance [12]

Group 1 - The company held its 28th meeting of the 10th Board of Directors on June 6, 2025, with all 9 directors present [2][3] - The board approved the strategic project for proton medical treatment [4] - The board also approved a capital increase of 500 million RMB from the controlling shareholder to its wholly-owned subsidiary, CGN Medical Technology (Mianyang) Co., Ltd [5][21] Group 2 - The capital increase will allow the subsidiary to develop proton medical technology and will maintain the subsidiary's status as a controlled entity of the company [21][34] - The board's decision on the capital increase was made with the avoidance of related directors, ensuring compliance with regulations [22][61] - The company plans to hold its 2024 annual shareholders' meeting on June 30, 2025 [41][42] Group 3 - The company approved revisions to its articles of association and management regulations during the board meeting [10][13] - The independent directors unanimously agreed that the transaction pricing was fair and would not affect the company's independence [36][61] - The company has had previous related transactions amounting to 37.88 million RMB with its controlling shareholder in 2025 [37]